期刊文献+

氨氯地平加替米沙坦或复方阿米洛利联合治疗对原发性高血压左心室肥厚患者校正的Q-T离散度的影响 被引量:3

Effects of amlodipine combined with telmisartan or with amiloride on QT dispersion in hypertensive patients with left ventricular hypertrophy
原文传递
导出
摘要 目的探讨不同联合降压治疗对原发性高血压左心室肥厚(LVH)患者校正的Q-T离散度(QTcd)的影响。方法入选原发性高血压患者111例,包括单纯高血压患者60例(男34例,女26例),年龄(60.7±5.6)岁,及原发性高血压LVH患者51例(男28例,女23例),年龄(61.8±7.0)岁。原发性高血压LVH患者随机分为低剂量氨氯地平(2.5mg/d)加替米沙坦(40mg/d)组(n=26)和氨氯地平(2.5mg/d)加复方阿米洛利(半片/d)组(n=25),治疗1年。于治疗前后分别行心动超声检查,检测左心室质量指数(LVMI)等指标、测量QT间期(QT)、校正的QT间期(QTc)及QTcd等,并进行比较分析。血压正常者56名(男31名,女25名)作为对照组,年龄(59.3±6.7)岁。结果高血压LVH组、单纯高血压组及对照组一般临床特征相似。高血压LVH患者QTcd[(34±10)ms]较对照组和单纯高血压患者明显延长(均P<0.05)。氨氯地平加替米沙坦组和氨氯地平加复方阿米洛利组患者基线血压、QT、QTc、QTcd、LVMI、室间隔厚度(IVST)、左心室后壁厚度(LVPWT)、左心室舒张末期内径(LVIDd)等临床指标差异无统计学意义(均P>0.05)。与治疗前比较发现,降压治疗1年后氨氯地平加替米沙坦和氨氯地平加复方阿米洛利联合治疗均能有效控制血压(均P<0.05),降低LVMI、IVST和LVPWT(均P<0.05),同时QTc、QTcd亦缩短(均P<0.05)。氨氯地平加替米沙坦组在降压及降低LVMI、IVST等方面优于氨氯地平加复方阿米洛利组(均P<0.05),且QTcd较氨氯地平加复方阿米洛利组明显缩短(P<0.01)。结论氨氯地平联合替米沙坦在有效控制血压,逆转LVH,改善心室厚度均匀性的同时,可明显改善心室肌复极同步性,其效果优于氨氯地平联合阿米洛利治疗。 Objective To investigate the effects of amlodipine combined with telmisartan or with amiloride on corrected QT dispersion(QTcd)in hypertensive patients with left ventricular hypertrophy(LVH).Methods Sixty primary hypertensive patients[male 34,female 26,average age(60.7±5.6)years]were enrolled as hypertensive group.Fifty-one primary hypertensive patients with LVH [male 28,female 23,average age(61.8±7.0)years] were randomly assigned to receive low-dose amlodipine(2.5mg/d)plus telmisartan(40mg/d)or low-dose amlodipine(2.5mg/d)plus compound amiloride(0.5tablet/d).All the patients were followed up for 1year.Upon enrollment and one year later left ventricular mass index(LVMI),QT,QTc and QTcd were measured.Fifty-six nomotensive individuals served as control [male 31,female 25,average age(59.3±6.7)years].Results Patient's conditions at enrollment were similar among hypertensive LVH,hypertensive and nomotensive groups.The values of QTcd in hypertensive LVH patients[(34±10)ms]were significantly higher than those in control(all P0.05).There were no significant differences in baseline blood pressure,LVMI,QTc and QTcd between amlodipine with telmisartan and amlodipine with amiloride groups.After 1year treatment,blood pressure was reducedsignificantly in both amlodipine with telmisartan and amlodipine with amiloride groups(both P0.05).Interventricular septal thickness(IVST),LVMI and QTcd decreased significantly compared to baseline values(all P0.05).The amlodipine with telmisartan had higher efficacy than amlodipine with amiloride group in reducing blood pressure,LVMI,IVST and left ventricular end diastolic diameter(LVPWT)(all P0.05),especially QTcd[(30±7)vs(34±7)ms,P0.05].Conclusion The combination of amlodipine and telmisartan was superior to amlodipine with amiloride group in controling blood pressure,attenuating LVH and improveing the heterogeneity ventricular repolarization.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2011年第12期1129-1133,共5页 Chinese Journal of Hypertension
基金 国家十一五科技支撑计划--高血压综合防治研究(2006BAI01A03) 国家自然科学基金资助项目(30871042)
关键词 高血压 左心室肥厚 Q-T离散度 Hypertension Left ventricular hypertrophy QT dispersion
  • 相关文献

参考文献9

  • 1田刚,鲁敏,韩克,卢群,王鑫.氨氯地平加替米沙坦或复方阿米洛利联合治疗对原发性高血压左心室肥厚患者血浆基质金属蛋白酶9和基质金属蛋白酶组织抑制物1的影响[J].中华高血压杂志,2010,18(9):869-874. 被引量:4
  • 2Malmqvist K,Kahan T,Edner M,et al.Cardiac repolarization and its relation to ventricular geometry and rate in reverse remodelling during antihypertensive therapy with irbesartan or atenolol:results from the SILVHIA study Cardiac repolarization in hypertension[J].J Hum Hypertens,2007,21(12):956-965.
  • 3Izumi R,Shinohata R,Ohmaru N.QT Dispersion measured by automatic computerized12-lead electrocardiography contributes significantly to detection of left ventricular hypertrophy in Japanese patients[J].J Internat Med Res,2011,39(1):51-63.
  • 4Dimopoulos S,Nicosia F,Turini D,et al.Prognostic evaluation of QT-Dispersion in elderly hypertensive and normotensive patients[J].Pac Clin Electrophys,2009,32(11):1381-1387.
  • 5Porthan K,Virolainen J,Hiltunen TP,et al.Relationship of electrocardiographic repolarization measures to echocardiographic left ventricular mass in men with hypertension[J].J Hypertens,2007,25(9):1951-1957.
  • 6Eva D,Ricardo C,Ricardo G,et al.AngiotensinⅡ,angiotensinⅡantagonists and spironolactone and their modulation of cardiac repolarization[J].Trend Pharmac Sci,2005,26(3):155-161.
  • 7Fabio G,Ferdinando Fi,Poupak F,et al.Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy[J].Biomedicine&Pharmacotherapy,2010,64(8):516-520.
  • 8Lasse O,Markku SN,Lauri T,et al.Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients:The losartan intervention for endpoint reduction(LIFE)study[J].Am Heart J,2003,145(5):919-925.
  • 9卢群,鲁敏,韩克,田刚.氨氯地平联合替米沙坦对高血压左心室肥厚患者血浆Ⅰ、Ⅲ型胶原代谢标记物的影响[J].中华高血压杂志,2011,19(3):257-262. 被引量:9

二级参考文献20

  • 1Dhingra R, Pencina MJ, Schrader P, et al. Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community[J]. Circulation, 2009,119 (8) : 1101-1107.
  • 2Duguay D, Pesant S, Deschepper CF, et al. Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine[J]. J Hypertens, 2007,25(6) : 1291-1299.
  • 3Nakayama H, Bodi I, Maillet M, et al. The IP3 Receptor Regulates Cardiac Hypertrophy in Response to Select Stimuli[J]. Circ Res,2010,107(5) :659-666.
  • 4Sugimoto M, Masutani S, M Seki M, et al. High serum levels of procollagen type Ⅲ N-terminal amino peptide in patients with congenital heart disease[J]. Heart, 2009,95 (24) : 2023-2028.
  • 5Cerisano G, Parodi G, Dovellini EV, etal. Time course of serum collagen types Ⅰ and Ⅲ metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension collagen turnover after infarction in hypertensives [J]. J Hum Hypertens,2009,23(1) :40-47.
  • 6Losi MA, Memoli B, Contaldi C, et al. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis[J]. Nephrol Dial Transplant, 2010,25 (6): 1950-1954.
  • 7Henderson BC, Sen U, Reynolds C, et al. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone[J]. Int J Biol Sci, 2007,3 ( 6 ) 385-392.
  • 8Ferreira DN, Katayama IA, Oliveira IB, et al. Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in wistar rats[J]. J Nutr, 2010,140 (10) :1742-1751.
  • 9Zhong J, Basu R, Guo D, et al. Angiotensin-eonverting enzyme Ⅱ suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunetion[J]. Circulation,2010,122(7) :717-728.
  • 10Gusev K, Domenighetti AA, Delbridge LMD, etal. Angiotensin Ⅱ-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling[J]. Circ Res, 2009,105 ( 1 ) : 42-50.

共引文献11

同被引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部